About: Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 February 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в лютому 2000 (uk) im Februar 2000 veröffentlichter wissenschaftlicher Artikel (de) wüsseschaftlicher Artikel, wo im Hornig 2000 veröffentlicht worden isch (gsw) artículu científicu espublizáu en febreru de 2000 (ast) artikull shkencor i botuar më 01 shkurt 2000 (sq) scientific article published on 01 February 2000 (en)
publication date	wds:Q73479857-1E8D9BED-3E54-4634-A236-FAC8E90AA573
publication date	2000-02-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73479857-F493C250-5319-4A8F-A593-20BEA14D5A3F
language of work or name	English
cites work	wds:Q73479857-007EC8A9-5FE0-480F-A8CD-C9F993056C10 wds:Q73479857-0F9DC41F-E642-4A42-8B19-28BF38A1AA5A wds:Q73479857-2BA582E4-1D1D-4201-9C46-A6A2B9615559 wds:Q73479857-3FF65F98-DF42-41F1-A778-65527718AB14 wds:Q73479857-4DB45494-1D11-49D0-848A-A8ED4C6232FF wds:Q73479857-5173ABD0-85F3-49CB-88B4-636DEC1B692A wds:Q73479857-77855C35-4784-401A-A4E3-B4906DCA02B3 wds:Q73479857-99875EBA-5821-4AE4-883C-7754E682150E wds:Q73479857-B629EA63-CAEE-487C-B040-1294133F22F0 wds:Q73479857-FBB8EF11-D3B7-41DB-94BE-DB64E2DFB9DD
cites work	A Comparison of Recombinant Hirudin with Heparin for the Treatment of Acute Coronary Syndromes Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators Rat model of arterial thrombosis induced by ferric chloride Evidence for a rebound coagulation phenomenon after cessation of a 4-hour infusion of a specific thrombin inhibitor in patients with unstable angina pectoris Hirudin in acute myocardial infarction. Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9B trial A multicenter, randomized study of argatroban versus heparin as adjunct to tissue plasminogen activator (TPA) in acute myocardial infarction: myocardial infarction with novastan and TPA (MINT) study Antithrombotic effects of YM-60828, a newly synthesized factor Xa inhibitor, in rat thrombosis models and its effects on bleeding time Low-molecular-weight heparin (fragmin) and thrombin active-site inhibitor (argatroban) compared in experimental arterial and venous thrombosis and bleeding time. Direct thrombin inhibitors in cardiovascular disease
author name string	wds:Q73479857-0A0F999E-C566-4469-ADE3-CBED76C4680F wds:Q73479857-2A73168C-23A3-4B57-BB75-F493BB6730B8 wds:Q73479857-389F5D12-8C11-4C36-937D-464A7F7498C5 wds:Q73479857-3D6E42AD-5B37-4075-8825-315EF0348526 wds:Q73479857-40CBB8E6-C41E-453C-BFAA-527421CD3804 wds:Q73479857-47E1D228-E1C9-46CD-A174-6BB686AD6D31 wds:Q73479857-B6F91BCB-1870-4045-86DD-61B90CE9C76B wds:Q73479857-D2E3C490-76CC-4F94-9289-7A016CF06114 wds:Q73479857-E89FA210-8F67-4DE2-A600-B59CCAF67A00 wds:Q73479857-E9D4F3B1-9951-4BCD-ACBF-01E271758C0A wds:Q73479857-FC435BB4-C2B7-4CCA-B789-0484EBF5CC50
author name string	K Brown R Bentley S Klein M Perrone S Morgan D Colussi J Bostwick V Chu C Heran M Czekaj C Kasiewski
rdfs:label	Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis (en) Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis (nl) Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis (sq)
skos:prefLabel	Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis (en) Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis (nl) Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis (sq)
name	Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis (en) Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis (nl) Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis (sq)
author	wds:Q73479857-55043766-C0FF-4D78-8A90-3780ECC6CD3F
author	Robert Leadley
title	wds:Q73479857-F5A0DB83-89A0-4E58-BEA9-C2B6259B3AAB
title	Antithrombotic efficacy of RPR208566, a novel factor Xa inhibitor, in a rat model of carotid artery thrombosis (en)
page(s)	wds:Q73479857-5A7746D7-6B65-4B56-8E41-244104A755AB
page(s)	201-207
instance of	wds:Q73479857-A4BE883B-3E03-4C6C-BEB7-F9CA4787C9C1
instance of	scholarly article
main subject	wds:Q73479857-25DBD86F-D699-406C-9DE6-8E6A6EFAAF0E wds:Q73479857-A7493FF8-F665-4837-91C7-9040041287EE
main subject	thrombosis carotid artery thrombosis
PubMed ID	wds:Q73479857-1CD9E0D4-799D-42BB-B3E2-2A0136E8B7F6
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10688985
PubMed ID	10688985
published in	wds:Q73479857-A0613D14-8FFE-4EFD-BA93-88625A6CF2B5
published in	European Journal of Pharmacology
issue	wds:Q73479857-1FD6BDB8-5742-4242-ACC0-14A7A0772714
volume	wds:Q73479857-F6FAEAE6-AB7E-4C7A-9980-A924E2386705
issue	2-3
volume	389
DOI	wds:Q73479857-B130FAA7-7443-4BD2-B2B2-365B6B377786
DOI	http://dx.doi.org/10.1016/S0014-2999(99)00902-4
DOI	10.1016/S0014-2999(99)00902-4
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73479857
is cites work of	New advances in the discovery of thrombin and factor Xa inhibitors The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis Contribution of in vivo models of thrombosis to the discovery and development of novel antithrombotic agents. The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration Evaluation of antithrombotic activity of thrombin DNA aptamers by a murine thrombosis model Design, synthesis and biological activity of YM-60828 derivatives: potent and orally-bioavailable factor Xa inhibitors based on naphthoanilide and naphthalensulfonanilide templates Troubleshooting the rabbit ferric chloride-induced arterial model of thrombosis to assess in vivo efficacy of antithrombotic drugs. Design, synthesis and biological activity of YM-60828 derivatives. Part 2: potent and orally-bioavailable factor Xa inhibitors based on benzothiadiazine-4-one template Discovery and characterization of a potent and selective non-amidine inhibitor of human factor Xa Timing of Heparin Administration Modulates Arterial Occlusive Thrombotic Response in Rats
is cites work of	wds:Q34014342-C265D784-9AA9-451D-8C15-65DC533E77C8 wds:Q35239708-4C654DD7-49ED-49BC-85F8-C9EA7C28EBD3

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software